Assessment of HAE prophylaxis transition from androgen therapy to berotralstat: A subset analysis of the APeX-S trial

Assessment of HAE prophylaxis transition from androgen therapy to berotralstat: A subset analysis of the APeX-S trial

Background: Given the recent approval of oral berotralstat in several countries for hereditary angioedema (HAE) prophylaxis, transition from long-term androgens to berotralstat may occur in clinical practice. The open-label, Phase II APeX-S trial provided an opportunity to assess the safety and effe...

Full description

Bibliographic Details
Main Authors: Jonny G. Peter, MB ChB, MMed, FCP (SA), PhD, Bhavisha Desai, PharmD, Dianne Tomita, MPH, Phil Collis, PhD, Marcin Stobiecki, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:World Allergy Organization Journal
Subjects:
Angioedemas
Hereditary
Androgens
Berotralstat
Treatment switching
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455123001011

Internet

http://www.sciencedirect.com/science/article/pii/S1939455123001011

Similar Items